Medicamen Biotech Ltd Q2 FY2023-2024 Results: Summary

Revenue
₹44.09Cr
Net Profits
₹1.51Cr
Net Profit Margins
3.42%

Highlights

Revenue:

Medicamen Biotech Ltd’s revenue jumped 29.45% since last year same period to ₹44.09Cr in the Q2 2023-2024. On a quarterly growth basis, Medicamen Biotech Ltd has generated 4.18% jump in its revenue since last 3-months.

Net Profits:

Medicamen Biotech Ltd’s net profit fell -58.06% since last year same period to ₹1.51Cr in the Q2 2023-2024. On a quarterly growth basis, Medicamen Biotech Ltd has generated -63.88% fall in its net profits since last 3-months.

Net Profit Margins:

Medicamen Biotech Ltd’s net profit margin fell -67.6% since last year same period to 3.42% in the Q2 2023-2024. On a quarterly growth basis, Medicamen Biotech Ltd has generated -65.33% fall in its net profit margins since last 3-months.

FAQs

The revenue for Medicamen Biotech Ltd in the Q2 results 2023 was ₹44.09Cr.

The net profit for Medicamen Biotech Ltd in the Q2 results 2023 was ₹1.51Cr.

The net profit margin for Medicamen Biotech Ltd in the Q2 results 2023 was 3.42%.

The revenue for Medicamen Biotech Ltd in the Q2 results 2022 was ₹34.06Cr.

The net profit for Medicamen Biotech Ltd in the Q2 results 2022 was ₹3.60Cr.

The net profit margin for Medicamen Biotech Ltd in the Q2 results 2022 was 10.57%.